Basic Agreement on Biliopancreatic Endoscopic Devices in the Gastroenterology Field
First written in FY2019-Q3. 2 of 4 entries say "Restated". Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022AdvancedAnnual report
「We entered into an exclusive domestic distribution agreement with OLYMPUS CORPORATION for Tornus ES, an endoscopic therapeutic dilator for the biliary and pancreatic area developed by the Group.」
For Tornus ES, developed in the gastrointestinal and biliary and pancreatic fields, the company demonstrated concrete progress in sales deployment through the execution of an exclusive domestic distribution agreement with OLYMPUS CORPORATION. - FY2021RestatedAnnual report
「In the Japanese market, the company has been launching new products ahead of other markets worldwide and plans to shift some of its own-brand gastrointestinal products to direct sales from July 2021.」
The company continues to pursue expansion into the gastrointestinal field and the transition to direct sales of proprietary-brand products as initiatives to expand treatment sites and treatment areas. - FY2019RestatedAnnual report
「With respect to OEM-related products, in the gastrointestinal field, we leveraged technologies developed in the cardiovascular field to develop Fielder 18, a 0.018-inch (0.46 mm) guidewire, the smallest-diameter guidewire for biliary and pancreatic endoscopic procedures.」
In connection with the basic agreement on biliary and pancreatic endoscopic devices, the company developed Fielder 18 in the gastrointestinal field, demonstrating concrete progress toward commercializing the product. - FY2019-Q3First statedAnnual report
「Execution of a basic agreement on biliary and pancreatic endoscopic devices in the gastrointestinal field」
The execution of a basic agreement on biliary and pancreatic endoscopic devices in the gastrointestinal field is separately identified for the first time as a new specific initiative for expanding products and treatment areas and creating new businesses.